These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12853748

  • 1. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine.
    Stringer JS, Sinkala M, Chapman V, Acosta EP, Aldrovandi GM, Mudenda V, Stout JP, Goldenberg RL, Kumwenda R, Vermund SH.
    AIDS; 2003 Jul 25; 17(11):1659-65. PubMed ID: 12853748
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL, International PACTG 316 Team.
    JAMA; 2002 Jul 10; 288(2):189-98. PubMed ID: 12095383
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024.
    Chi BH, Wang L, Read JS, Sheriff M, Fiscus S, Brown ER, Taha TE, Valentine M, Goldenberg R.
    AIDS; 2005 Nov 04; 19(16):1857-64. PubMed ID: 16227794
    [Abstract] [Full Text] [Related]

  • 10. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
    Lallemant M, Le Coeur S, Sirirungsi W, Cressey TR, Ngo-Giang-Huong N, Traisathit P, Klinbuayaem V, Sabsanong P, Kanjanavikai P, Jourdain G, Mcintosh K, Koetsawang S, PHPT-5 study investigators.
    AIDS; 2015 Nov 28; 29(18):2497-507. PubMed ID: 26372485
    [Abstract] [Full Text] [Related]

  • 11. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
    Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB.
    AIDS; 1999 Mar 11; 13(4):479-86. PubMed ID: 10197376
    [Abstract] [Full Text] [Related]

  • 12. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.
    Chi BH, Sinkala M, Mbewe F, Cantrell RA, Kruse G, Chintu N, Aldrovandi GM, Stringer EM, Kankasa C, Safrit JT, Stringer JS.
    Lancet; 2007 Nov 17; 370(9600):1698-705. PubMed ID: 17997151
    [Abstract] [Full Text] [Related]

  • 13. In-home HIV testing and nevirapine dosing by traditional birth attendants in rural Zambia: a feasibility study.
    Brennan AT, Thea DM, Semrau K, Goggin C, Scott N, Pilingana P, Botha B, Mazimba A, Hamomba L, Seidenberg P.
    J Midwifery Womens Health; 2014 Nov 17; 59(2):198-204. PubMed ID: 24106818
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.
    Arrivé E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, Leroy V, Perre PV, Rouzioux C, Dabis F, Ghent Group on HIV in Women and Children.
    Int J Epidemiol; 2007 Oct 17; 36(5):1009-21. PubMed ID: 17533166
    [Abstract] [Full Text] [Related]

  • 15. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
    Jackson JB, Parsons T, Musoke P, Nakabiito C, Donnell D, Fleming T, Mirochnick M, Mofenson L, Fowler MG, Mmiro F, Guay L.
    AIDS; 2006 Jan 09; 20(2):217-22. PubMed ID: 16511414
    [Abstract] [Full Text] [Related]

  • 16. Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.
    Frank M, von Kleist M, Kunz A, Harms G, Schütte C, Kloft C.
    Antimicrob Agents Chemother; 2011 Dec 09; 55(12):5529-40. PubMed ID: 21947390
    [Abstract] [Full Text] [Related]

  • 17. Nevirapine resistance after single dose prophylaxis.
    Eshleman SH, Jackson JB.
    AIDS Rev; 2002 Dec 09; 4(2):59-63. PubMed ID: 12152519
    [Abstract] [Full Text] [Related]

  • 18. Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
    Cressey TR, Jourdain G, Lallemant MJ, Kunkeaw S, Jackson JB, Musoke P, Capparelli E, Mirochnick M.
    J Acquir Immune Defic Syndr; 2005 Mar 01; 38(3):283-8. PubMed ID: 15735445
    [Abstract] [Full Text] [Related]

  • 19. Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission.
    Chi BH, Chintu N, Cantrell RA, Kankasa C, Kruse G, Mbewe F, Sinkala M, Smith PJ, Stringer EM, Stringer JS.
    J Acquir Immune Defic Syndr; 2008 Jun 01; 48(2):220-3. PubMed ID: 18520682
    [Abstract] [Full Text] [Related]

  • 20. Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India.
    Gupta A, Gupte N, Sastry J, Bharucha KE, Bhosale R, Kulkarni P, Tripathy S, Nayak U, Phadke M, Bollinger RC, BJMC-JHU MIT Study Team.
    Indian J Med Res; 2007 Aug 01; 126(2):131-4. PubMed ID: 17932438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.